{"id":"https://genegraph.clinicalgenome.org/r/f2384955-1cf5-4183-876a-81a8b9aa775dv1.0","type":"EvidenceStrengthAssertion","dc:description":"STX11 was first reported in relation to autosomal recessive familial hemophagocytic lymphohistiocytosis 4 (FHL4) in 2005 (zur Stadt U et al., 2005, PMID: 15703195). FHL is characterized by episodes of severe and overwhelming systemic immune activation which is often lethal in the absence of appropriate treatment and subsequent allogeneic hematopoietic cell transplantation (HCT). Typical features include fever, splenomegaly, cytopenias, hypertriglyceridemia, hypofibrinogenemia, hyperferritinemia, elevated levels of soluble IL-2 receptor, decreased or absent NK cell function, and hemophagocytosis observed on pathologic inspection of bone marrow or other tissues. Patients with defects in syntaxin 11 result in severely compromised NK degranulation and cytotoxicity. STX11 is expressed in many tissues, but with regard to the immune system, Syntaxin 11 is necessary for normal NK cell and CD8+T cell cytotoxic granule exocytosis and has been implicated in being involved in neutrophil granule exocytosis as well. The exact molecular mechanism of STX11 is not clear. This curation includes 11 variants (including in-frame deletions, missense, nonsense, and frameshift) found in 10 probands from two publications (PMIDs: 20486178, 16582076, 24459464, 26709266, 21298754, 19967551, 31207086 and 31770233). Additional cases are available in the literature however the maximum score for genetic evidence has been reached. A role in disease is supported by increased expression of STX11 in NK cells and CD8+ T cells, as well as in NK92 cells (PMID:17525286). Functional alteration in the patient's cells also showed how a mutation resulted in a complete loss of STX11 function (PMID: 20486178). A Stx11−/− mouse model demonstrated the phenotypes associated with FHL4 and exhibited a defective degranulation and cytotoxic activity of lymphocytes in vitro, confirming the critical role of this SNARE protein in cytotoxic granule exocytosis. Recuse of the phenotype was also seen in this same mouse model (PMID:23160464). In summary, STX11 is definitively associated with autosomal recessive FHL4. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/f2384955-1cf5-4183-876a-81a8b9aa775d","GCISnapshot":"https://genegraph.clinicalgenome.org/r/9844bf07-9887-4a28-b644-467b664fcb80","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/9844bf07-9887-4a28-b644-467b664fcb80_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10145","date":"2023-09-26T13:17:24.623Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/9844bf07-9887-4a28-b644-467b664fcb80_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10145","date":"2023-09-19T16:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9844bf07-9887-4a28-b644-467b664fcb80_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dcd792df-a758-4bc1-95c5-add00b48f3df_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/95c2a627-2882-4905-a379-c39d381a363b","type":"EvidenceLine","dc:description":"Consanguineous parents were reported for this proband. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/95c2a627-2882-4905-a379-c39d381a363b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Analysis of the CD107a degranulation function of the proband. The CD107a degranulation function of the proband was obviously declined in cytotoxic T lymphocytes (ΔMFI: 1.4%, normal ≥2.8%) and NK cells (ΔCD107a = 0.47%, normal >10%).","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/95c2a627-2882-4905-a379-c39d381a363b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31770233","allele":{"id":"https://genegraph.clinicalgenome.org/r/762ba756-bed6-4f10-af2b-5bfa9a352cf7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003764.4(STX11):c.49C>T (p.Gln17Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA365948427"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/dcd792df-a758-4bc1-95c5-add00b48f3df","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31770233","rdfs:label":"G3P3 ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/762ba756-bed6-4f10-af2b-5bfa9a352cf7"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0003270","obo:HP_0031364","obo:HP_0003281","obo:HP_0012156","obo:HP_0001945","obo:HP_0001876","obo:HP_0031691"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/95c2a627-2882-4905-a379-c39d381a363b_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/69533282-c348-4613-a638-738a75d4e588_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8c5c9f05-0edc-4222-ab67-1b88c48f23ea","type":"EvidenceLine","dc:description":"in pervious patient (Marsh RA, et al., 2010, PMID: 20486178)\n\nLatino/admixed American 1/34584(0.00002892)\nhttps://gnomad.broadinstitute.org/variant/6-144507837-G-T\n","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8c5c9f05-0edc-4222-ab67-1b88c48f23ea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31207086","allele":{"id":"https://genegraph.clinicalgenome.org/r/946652f0-d169-4126-86d6-893784a11402","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003764.4(STX11):c.73G>T (p.Glu25Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA365948476"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.75},{"id":"https://genegraph.clinicalgenome.org/r/eb3d8352-fa60-4d56-9d4b-3c6ec82842f1","type":"EvidenceLine","dc:description":"Predicted null was not confirmed in study\n\nLatino/admixed American 2/34516 (0.00005794)\nhttps://gnomad.broadinstitute.org/variant/6-144508512-C-T","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eb3d8352-fa60-4d56-9d4b-3c6ec82842f1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31207086","allele":{"id":"https://genegraph.clinicalgenome.org/r/e44786bc-d012-4243-af34-6251b260bed7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003764.4(STX11):c.748C>T (p.Gln250Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4031781"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.75},{"id":"https://genegraph.clinicalgenome.org/r/69533282-c348-4613-a638-738a75d4e588","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31207086","rdfs:label":"18 month male","ageType":"AgeAtReport","ageUnit":"Months","ageValue":18,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/946652f0-d169-4126-86d6-893784a11402"},{"id":"https://genegraph.clinicalgenome.org/r/e44786bc-d012-4243-af34-6251b260bed7"}],"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"The patient had a high sIL-2R level (9040 U/mL)","phenotypes":["obo:HP_0002155","obo:HP_0001744","obo:HP_0001876","obo:HP_0001945"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/8c5c9f05-0edc-4222-ab67-1b88c48f23ea_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/eb3d8352-fa60-4d56-9d4b-3c6ec82842f1_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/0bb37adf-2317-4b48-8cb6-a0e39f920a7f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fa8a726f-9d80-4e22-aefd-7286eaa0f30b","type":"EvidenceLine","dc:description":"Homozygous due to consanguinity.\n\nSouth Asian 2/30598 (0.00006536) https://gnomad.broadinstitute.org/variant/6-144507937-T-C","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fa8a726f-9d80-4e22-aefd-7286eaa0f30b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"\n","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/fa8a726f-9d80-4e22-aefd-7286eaa0f30b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24459464","allele":{"id":"https://genegraph.clinicalgenome.org/r/a2a90563-5914-47d6-b976-b9b17a94dbab","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003764.4(STX11):c.173T>C (p.Leu58Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA267503"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/0bb37adf-2317-4b48-8cb6-a0e39f920a7f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24459464","rdfs:label":"Patient B","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":5,"allele":{"id":"https://genegraph.clinicalgenome.org/r/a2a90563-5914-47d6-b976-b9b17a94dbab"},"detectionMethod":"Stx11 mutations were generated by site-directed mutagenesis.","firstTestingMethod":"Other","phenotypeFreeText":"Deficient NK cell activity and degranulation ","phenotypes":["obo:HP_0001744","obo:HP_0002240","obo:HP_0001945","obo:HP_0011112","obo:HP_0003281"],"previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/fa8a726f-9d80-4e22-aefd-7286eaa0f30b_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/271defdd-97c3-41b7-ba59-4e54cb75b8d5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0ef06abd-e6b7-494f-b3de-0a79897c2640","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0ef06abd-e6b7-494f-b3de-0a79897c2640_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19967551","allele":{"id":"https://genegraph.clinicalgenome.org/r/5ac55a66-2849-4398-b79c-d9b13f5a4633","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003764.4(STX11):c.581_584del (p.Leu194ProfsTer3)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA915944442"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/271defdd-97c3-41b7-ba59-4e54cb75b8d5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19967551","rdfs:label":"Patient 2","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":13,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5ac55a66-2849-4398-b79c-d9b13f5a4633"},"detectionMethod":"direct sequencing ","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"elevated aminotransferases","phenotypes":["obo:HP_0003281","obo:HP_0011900","obo:HP_0002155","obo:HP_0001744","obo:HP_0001903","obo:HP_0001433","obo:HP_0001945","obo:HP_0001876","obo:HP_0001396"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/0ef06abd-e6b7-494f-b3de-0a79897c2640_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/ec0804a8-5d86-4544-8a1a-e04a0b423672_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1db0602b-1746-44b4-80e8-b782dda19a89","type":"EvidenceLine","dc:description":"Consanguineous parents were reported for this proband\n\nEuropean (non-finnish): 1/112278 (0.000008906) https://gnomad.broadinstitute.org/variant/6-144508566-C-T","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1db0602b-1746-44b4-80e8-b782dda19a89_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16582076","allele":{"id":"https://genegraph.clinicalgenome.org/r/f1fc6d73-56f1-4089-9dfe-26cccd0711dc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003764.4(STX11):c.802C>T (p.Gln268Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA253453"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/ec0804a8-5d86-4544-8a1a-e04a0b423672","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16582076","rdfs:label":"Patient  C1","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f1fc6d73-56f1-4089-9dfe-26cccd0711dc"},"detectionMethod":"direct DNA sequencing","firstTestingMethod":"Other","phenotypeFreeText":"Haemophagocytosis","phenotypes":["obo:HP_0003281","obo:HP_0002240","obo:HP_0002155","obo:HP_0001744","obo:HP_0001873","obo:HP_0011900","obo:HP_0001945","obo:HP_0001903"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1db0602b-1746-44b4-80e8-b782dda19a89_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/906371b6-b435-473b-acc8-968516db50a0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/775bbaed-24f0-419d-ba20-bf85f3885969","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/775bbaed-24f0-419d-ba20-bf85f3885969_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26709266","allele":{"id":"https://genegraph.clinicalgenome.org/r/aeb8fda0-41de-4507-bfbf-636775961802","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003764.4(STX11):c.650T>C (p.Leu217Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA365949700"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/906371b6-b435-473b-acc8-968516db50a0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26709266","rdfs:label":"33 month old boy","ageType":"AgeAtReport","ageUnit":"Months","ageValue":33,"allele":{"id":"https://genegraph.clinicalgenome.org/r/aeb8fda0-41de-4507-bfbf-636775961802"},"detectionMethod":"Direct sequencing of exons and exon-intron boundaries of genomic DNA extracted from peripheral blood leukocytes","firstTestingMethod":"Exome sequencing","phenotypeFreeText":" histiocytic hyperplasia","phenotypes":["obo:HP_0012156","obo:HP_0001882","obo:HP_0003281","obo:HP_0001873","obo:HP_0002240","obo:HP_0001945","obo:HP_0001903"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/775bbaed-24f0-419d-ba20-bf85f3885969_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/f6dfba3a-6647-4bca-9859-9b3282db4580_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/895de15f-1389-4e2e-ba64-5fc7b2519147","type":"EvidenceLine","dc:description":"Consanguineous parents were reported for this proband. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/895de15f-1389-4e2e-ba64-5fc7b2519147_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16582076","allele":{"id":"https://genegraph.clinicalgenome.org/r/0a96e082-18b8-46ad-90bc-f374a4d4fd2f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003764.4(STX11):c.369_376delinsTGG (p.Val124GlyfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA253451"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/f6dfba3a-6647-4bca-9859-9b3282db4580","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16582076","rdfs:label":"Patient B1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/0a96e082-18b8-46ad-90bc-f374a4d4fd2f"},"detectionMethod":"Direct Sequencing ","firstTestingMethod":"Other","phenotypeFreeText":" Haemophagocytosis, Neurological disease relates to the entire course of the disease.","phenotypes":["obo:HP_0011344","obo:HP_0002240","obo:HP_0001945","obo:HP_0003281","obo:HP_0003073","obo:HP_0001873","obo:HP_0002155","obo:HP_0001744","obo:HP_0001875"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/895de15f-1389-4e2e-ba64-5fc7b2519147_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/451d9eb0-b84e-4632-a77c-092d2684ac6d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2e93be54-daf1-45f2-a50f-c7b3c0ad5699","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2e93be54-daf1-45f2-a50f-c7b3c0ad5699_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21298754","allele":{"id":"https://genegraph.clinicalgenome.org/r/803c204f-28af-4715-8758-10ee379b039b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003764.4(STX11):c.687dup (p.Gln230AlafsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658822725"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/451d9eb0-b84e-4632-a77c-092d2684ac6d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21298754","rdfs:label":"Patient B:1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/803c204f-28af-4715-8758-10ee379b039b"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0003281","obo:HP_0012156","obo:HP_0001945","obo:HP_0001875","obo:HP_0012178","obo:HP_0001873","obo:HP_0002240"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/2e93be54-daf1-45f2-a50f-c7b3c0ad5699_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/9844bf07-9887-4a28-b644-467b664fcb80_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1d9925f2-9236-4dc6-9cf8-2ebc58bc1c0a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16582076","rdfs:label":"Family B ","estimatedLodScore":0.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/1d9925f2-9236-4dc6-9cf8-2ebc58bc1c0a","type":"Family","rdfs:label":"Family B ","member":{"id":"https://genegraph.clinicalgenome.org/r/f6dfba3a-6647-4bca-9859-9b3282db4580"}},"phenotypeFreeText":" Haemophagocytosis, Neurological disease relates to the entire course of the disease.","phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001875","obo:HP_0003073","obo:HP_0001744","obo:HP_0002155","obo:HP_0011344","obo:HP_0002240","obo:HP_0001945","obo:HP_0001873","obo:HP_0003281"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/f6dfba3a-6647-4bca-9859-9b3282db4580"}},{"id":"https://genegraph.clinicalgenome.org/r/a26ad82d-e2ca-442d-a151-fa2d27d93344_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20486178","rdfs:label":"Family Patient 1 and 2","estimatedLodScore":0.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/a26ad82d-e2ca-442d-a151-fa2d27d93344","type":"Family","rdfs:label":"Family Patient 1 and 2","ethnicity":{"id":"cg:HispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/54deba53-a318-418f-8f83-5b19d118638a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20486178","rdfs:label":"Patient 2","ageType":"AgeAtOnset","ageUnit":"Hours","allele":{"id":"https://genegraph.clinicalgenome.org/r/946652f0-d169-4126-86d6-893784a11402"},"ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Elevated soluble IL-2R","phenotypes":["obo:HP_0002155","obo:HP_0002240","obo:HP_0001744","obo:HP_0003281","obo:HP_0001876"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/beb210e8-48de-4815-b54d-db6eee98cc64_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20486178","allele":{"id":"https://genegraph.clinicalgenome.org/r/946652f0-d169-4126-86d6-893784a11402"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0012156","obo:HP_0003281","obo:HP_0001744","obo:HP_0001876","obo:HP_0002155","obo:HP_0002240","obo:HP_0001945"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/54deba53-a318-418f-8f83-5b19d118638a"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/a7872304-ffcf-4792-82aa-0990b7645f80_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e87cca79-6d97-40a2-af16-3ee914d53bce","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e87cca79-6d97-40a2-af16-3ee914d53bce_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20486178","allele":{"id":"https://genegraph.clinicalgenome.org/r/30f4a8c9-302e-44e0-b08c-cbd38752f72d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003764.4(STX11):c.106G>C (p.Glu36Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4031623"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d628f733-5de6-4056-b6c4-eff36bec447e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d628f733-5de6-4056-b6c4-eff36bec447e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20486178","allele":{"id":"https://genegraph.clinicalgenome.org/r/b4ff85f8-ab9c-4357-a5a0-2180966fd438","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003764.4(STX11):c.616G>C (p.Glu206Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA365949627"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a7872304-ffcf-4792-82aa-0990b7645f80","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20486178","rdfs:label":"Patient 3","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":5,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/b4ff85f8-ab9c-4357-a5a0-2180966fd438"},{"id":"https://genegraph.clinicalgenome.org/r/30f4a8c9-302e-44e0-b08c-cbd38752f72d"}],"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Elevated soluble IL-2","phenotypes":["obo:HP_0001945","obo:HP_0003281","obo:HP_0001698","obo:HP_0002240","obo:HP_0002202","obo:HP_0001876","obo:HP_0012156"],"previousTesting":false,"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/e87cca79-6d97-40a2-af16-3ee914d53bce_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/d628f733-5de6-4056-b6c4-eff36bec447e_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/54deba53-a318-418f-8f83-5b19d118638a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/beb210e8-48de-4815-b54d-db6eee98cc64","type":"EvidenceLine","dc:description":"Consanguineous parents were reported for this proband. \n\nwestern blotting was done ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/beb210e8-48de-4815-b54d-db6eee98cc64_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/54deba53-a318-418f-8f83-5b19d118638a"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/9844bf07-9887-4a28-b644-467b664fcb80_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9844bf07-9887-4a28-b644-467b664fcb80_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/75a89f3a-997e-45a1-b93b-4db8342a836f","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a34444c0-2d97-4607-898c-5ba68f12bcfe","type":"Finding","dc:description":"To investigate whether murine CTLs depend on STX11 for degranulation, they conducted experiments comparing wild-type (WT) CTLs with Stx11-deficient CTLs. It was observed that WT CTLs increased CD107 cell surface expression upon activation, indicating degranulation. In contrast, Stx11-deficient CTLs failed to degranulate upon T-cell receptor engagement. To confirm that the degranulation defect was indeed due to the absence of STX11, they introduced human STX11 into Stx11-deficient lymphocytes. This complementation restored the degranulation capacity of Stx11-deficient cells to normal levels. Mouse failed to control the LCMV infection to be a key factor in HLH pathogenesis.  LCMV infection induced all the features of HLH in the new Stx11−/− mouse. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23160464","rdfs:label":"Stx11−/− Murine Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0698114a-0024-4245-b892-75176c147024","type":"EvidenceLine","dc:description":"Only a portion of the disease phenotype was observed and restored \n","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a201b748-2774-4d0b-8eed-88b75a3727bb","type":"Finding","dc:description":"STX11 restored degranulation capacity of Stx11-deficient cells to WT levels ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23160464","rdfs:label":"Rescue of Stx11−/− Murine Model","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/9844bf07-9887-4a28-b644-467b664fcb80_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/15dc6aee-10a3-4e00-92ff-95cfd01e3e87","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c24fd6bf-06b4-4f77-ac4d-957949f4a966","type":"FunctionalAlteration","dc:description":"Results show that the E25X/E25X mutation in syntaxin 11 resulted in a complete loss of NK cell degranulation and cytotoxicity. Seen in figure 2,  NK cells carrying this mutation were unable to release cytotoxic granules and were ineffective at killing target cells.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20486178","rdfs:label":"Patient 1 K562 target cell chromium release assays "}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9844bf07-9887-4a28-b644-467b664fcb80_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/40d9d169-7326-40c3-beda-d0ce02aa743e","type":"EvidenceLine","dc:description":"This indicates their involvement in the formation of a functionally active SNARE complex essential for lytic granule exocytosis during cell-mediated cytotoxicity. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/327daea0-d6b0-4cf6-8074-a9bd422eb252","type":"Finding","dc:description":"Coimmunoprecipitation (co-IP) shows that STX11 associates with Munc18-2 in activated cytotoxic T lymphocytes (CLTs). ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28265073","rdfs:label":"Munc18-2 Interaction","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5d63f031-1c64-4b5f-9d08-4f118ea13531","type":"EvidenceLine","dc:description":"Based on Human Protein Atlas this protein is most abundant in immune cells, such as T and NK cells.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/63691273-5766-4c3b-b8b1-618b0f0d243b","type":"Finding","dc:description":"RNA from purified, unstimulated CD8+ T cells, and NK cells, as well as the NK-cell line NK92 was prepared and amplified by RT-PCR using primers specific for STX11. Transcripts of STX11 were expressed in primary unstimulated NK cells and CD8+ T cells, as well as in NK92 cells.  Stx11 was detected by Western blotting. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17525286","rdfs:label":"Expression of Stx11 in cytotoxic lymphocytes","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5}],"evidenceStrength":"Definitive","sequence":6931,"specifiedBy":"GeneValidityCriteria9","strengthScore":17,"subject":{"id":"https://genegraph.clinicalgenome.org/r/tGOao4Xm_Mg","type":"GeneValidityProposition","disease":"obo:MONDO_0011336","gene":"hgnc:11429","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_9844bf07-9887-4a28-b644-467b664fcb80-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}